Candace M. Polster focuses her practice on complex patent litigation, due diligence, and counseling clients with IP issues. Candace has experience litigating IP cases in US federal district courts, state courts, and at the US International Trade Commission. Prior to law school, she worked as a pharmaceutical chemist in research and development for 10 years at Eli Lilly where she gained experience with molecular synthesis, drug formulation development, medical device design, due diligence, and FDA regulatory filings.
Candace's technical background encompasses both small molecules and large molecules including proteins, peptides, antibodies, crystallization, genetic engineering, cell line development, and protein process purification. She is knowledgeable about organic chemistry, biochemistry, biotechnology, and analytical chemistry. As a chemist in industry, Candace gained experience with numerous chemical analytical tests and instruments such as PCR, ELISA, chromatography, mass spectrometry, NMR, DNA sequencing, and dissolution.
Her skill set also includes responding to FDA Form 483 inspections and maintaining FDA regulatory compliance. She has experience with drafting FDA New Drug Applications (NDAs) and Biologics License Applications (BLAs). In addition to pharmaceutical experience, Candace also has oil and gas industry exposure from her prior work with fractionation and distillation. Additionally, she worked in the agricultural industry by performing experiments with gene expression in new crop lines. During law school, Candace gained patent prosecution and litigation experience from a combination of law firm and in-house counsel work.
Indiana University Maurer School of Law, 2019, J.D.
Purdue University, 2007, B.S., Chemistry
US District Court for the Northern District of Illinois
Awards and Affiliations
Member, Practice Group of the Year, Intellectual Property, Law360 (2019)